Page last updated: 2024-10-27

fenoldopam and Polycystic Kidney Diseases

fenoldopam has been researched along with Polycystic Kidney Diseases in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.

Research Excerpts

ExcerptRelevanceReference
"Patients with polycystic kidney disease (PKD) are characterized with uncontrolled hypertension."1.51Ciliotherapy: Remote Control of Primary Cilia Movement and Function by Magnetic Nanoparticles. ( Ahsan, A; Kathem, SH; Luan, Z; Mohieldin, AM; Nauli, SM; Pala, R; Shamloo, K; Sherpa, RT; Zheng, JG; Zhou, J, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pala, R1
Mohieldin, AM1
Sherpa, RT1
Kathem, SH1
Shamloo, K1
Luan, Z1
Zhou, J1
Zheng, JG1
Ahsan, A1
Nauli, SM1

Other Studies

1 other study available for fenoldopam and Polycystic Kidney Diseases

ArticleYear
Ciliotherapy: Remote Control of Primary Cilia Movement and Function by Magnetic Nanoparticles.
    ACS nano, 2019, 03-26, Volume: 13, Issue:3

    Topics: Animals; Antihypertensive Agents; Cells, Cultured; Cilia; Drug Delivery Systems; Fenoldopam; Ferric

2019